Eight Wins, Nine Months and a Denominator That Doesn't Reconcile: Which Number Actually Settles the Adidas–Nike Running Race
**मुख्य उत्तर:** एडिडास ने 2025 में वर्ल्ड मैराथन मेजर्स की छह पूरी हुई दौड़ों के 12 खिताबों में से 8 जीते और तीसरी तिमाही में रनिंग राजस्व 19% बढ़ाया। कंपनी की एलीट 'इवो' लाइन 9 महीनों में विकसित हुई, जबकि उद्योग का सामान्य चक्र 18–24 महीने है। नाइकी ने 2019 में 12 में से 10 खिताब जीते थे। **मुख्य तथ्य:** - एडिडास रनिंग राजस्व तीसरी तिमाही 2025 में साल-दर-साल 19% बढ़ा; श्रेणी का पूर्ण राजस्व नहीं छापा गया। - एलीट इवो शू लाइन 9 महीने में विकसित हुई; उद्योग मानक 18–24 महीने; नवाचार टीम में 100 से अधिक लोग। - नाइकी ने 2019 में छह मेजर के 12 खिताबों में से 10 जीते; 2025 में सिडनी जुड़ने से सालाना खिताब 14 हो गए। - नाइकी रनिंग श्रेणी लगातार छह तिमाहियों में दोहरे अंक की बढ़त में; समूह राजस्व अनुमान भारी गिरावट पर। - बेंसन किप्रुटो एथेंस डेब्यू में दूसरे स्थान के बाद साइन हुए; शिकागो 2022, टोक्यो 2024, पेरिस कांस्य, न्यूयॉर्क खिताब। **स्रोत:** रॉयटर्स, नवंबर 2025 (व्यावसायिक खेल-उद्योग रिपोर्ट, न्यूयॉर्क मैराथन संदर्भ) **संबंधित प्रश्न-उत्तर:** प्रश्न: 2025 में एडिडास ने कितने मैराथन मेजर खिताब जीते? उत्तर: न्यूयॉर्क से पहले पूरी हुई छह मेजर दौड़ों के 12 खिताबों में से 8। प्रश्न: एडिडास की एलीट रनिंग शू लाइन कितने महीनों में विकसित हुई? उत्तर: 9 महीनों में, जबकि उद्योग का सामान्य विकास चक्र 18–24 महीने का है। प्रश्न: नाइकी का रनिंग कारोबार किस स्थिति में है? उत्तर: रनिंग श्रेणी लगातार छह तिमाहियों से दोहरे अंक की बढ़त दर्ज कर रही है, जबकि समूह राजस्व अनुमान भारी गिरावट की ओर है।
On the elite start list of the New York City Marathon, the eye snags first not on times but on a shoe count. Take the finish sheets of the six World Marathon Majors completed before New York this year: twelve titles distributed, eight to Adidas. The company's press note leads with that eight and attaches a sentence to it — wins are proof of innovation. My sheet carries three versions of the same figure: eight wins, eight of twelve, and eight of fourteen annual opportunities once Sydney entered the series. Change the denominator and the same eight slides from roughly sixty-seven per cent to fifty-seven. The press note prints none of the three denominators.

Across the years of marathon broadcasts I have watched, I have kept the habit of counting shoes on the start line. It came from football's transfer windows, where I learned that counting entrances proves nothing and counting exits proves everything. Marathons have no exit documents. An athlete is not registered in a window, no fee is recorded anywhere, and the day he stands on a start line in another brand's shoe, not one entry is made in any ledger. So this market looks cleaner than it is.
Context: the market after the super-shoe
This market divides into before 2026 and after. That year Nike put carbon plate and thick foam on the road with the Vaporfly and built a platform — a base on which successive generations could be stacked. Competition stayed comfortable while rivals copied the platform, because a platform can be copied. Adidas reshaped its development process from the ground up in 2026, and the elite line that followed — known internally as the Evo line — came together in nine months against an industry norm of eighteen to twenty-four.
Demand looked unusual this year too. London split its race across two days. New York drew roughly two hundred and fifty thousand applicants and expected record turnout. Inside the industry this is being called a participation heyday, the phase in which running becomes a lifestyle before it is a competition. The shoe sells in the hundreds of dollars, which is precisely where a sport's market ties itself to consumer discretionary spending.
The two companies' accounts are speaking different languages this year. Adidas running revenue rose nineteen per cent year on year in the third quarter, a quarter the company calls record-breaking. Nike's running category has posted double-digit growth for six consecutive quarters, and the company says its share of max-cushion nearly tripled. At group level, Nike's full-year revenue is forecast to fall steeply, with restructuring under way, divisions reshuffled and further job cuts. Both companies say the cost of competing in this space keeps rising.
The core analysis
Nine months against eighteen: the edge sits in process, not product
Once a shoe reaches the market, copying it takes months — foam density, plate geometry, upper mesh. What cannot be copied is the cycle in which the shoe is made. A nine-month elite development cycle against an eighteen-to-twenty-four-month norm is not merely speed; it is a structural advantage in cycle time. The window Nike opened in 2026 is halving every year.
Adidas's advantage sits in its organisational structure, not its product list — and copying an organisation is far more expensive for a rival than copying a shoe.
Behind that claim is a hard number that never reaches the press note. More than a hundred people work in the company's running-shoe innovation operation, against what was described as a few dozen some years ago. That figure weighs more than any advertising sentence, because it says where the money went — into process, not publicity. A second component attaches to it: the athlete feedback loop. The process is described plainly: test, refine, redevelop, and keep that loop running alongside the race calendar. A nine-month cycle is possible only if athletes race prototypes and send them back. That is why the athlete here is a co-developer rather than a pure endorser, and that capability travels from shoes into other performance categories.

The arithmetic of treating wins as proof
The company's argument is straightforward: we are winning, therefore our shoe is better. As a KPI it looks strong at first glance and begins to fracture at the second, because a race win blends four things — shoe quality, roster quality, course profile and race-day variance. A brand that signed an athlete ten years ago, before his value curve steepened, cannot separate the shoe's contribution from its own recruitment, and will naturally credit the shoe.
There is an entry here that usually goes unread. Adidas's recruitment network uses coaches, experts and athletes to identify signature talent as early as the youth level. An unknown share of the win delta therefore reflects talent identification rather than engineering. On my sheet these sit in separate columns, because they are two different expenditures: one in a laboratory, the other at the roadside.
The politics of the denominator
Now the number that stopped me first. In 2026 Nike won ten of the twelve titles across the six Majors — around eighty-three per cent. In 2026 Adidas won eight of twelve — around sixty-seven per cent, a derived figure of mine rather than a published one, and still awaiting verification. But in 2026 the Majors expanded from six to seven with Sydney, lifting annual titles from twelve to fourteen. Any year-on-year or cross-brand comparison requires that adjustment, and no press note will supply it.
When the denominator moves and the numerator holds, the number stops growing and starts speaking.
This is an old habit I do not hide: the clause was never the story, the spreadsheet was. Here the first tab counts titles, the second counts the calendar, and the third — the one nobody opens — shows that the two years cannot be compared at all until the denominators match.
The endorsement transfer market: the Kipruto purchase
In football a transfer reconciles through three things: the fee, the sell-on percentage and the registration date. Here none of the three exists. So I read this market the way I read a club's endorsement book: when the purchase was made, what the athlete was worth then, and which season the return landed in.
Adidas signed Benson Kipruto shortly after he finished second in his marathon debut in Athens — roughly ten years ago, before the peak, while the value curve was still flat. The return since is legible: Chicago 2026, Tokyo 2026, Olympic bronze in Paris, and a title defence in New York. That is the textbook buy-low, develop-high purchase — the model football clubs run through their academies, except the academy's product here is not a player but endorsement rights.
A system that signs athletes at youth level is, in substance, an academy for endorsement rights — and it is always cheaper than bidding at the peak.
Something else surfaces here that football's ledger never shows. When a player's contract ends at a club, an entry is made in his registration file — who left, when, who took him. In marathons an athlete quietly appears in another brand's shoe at contract end and nothing is recorded. Count exits, count entrances — here there is no register to count either. So when a company says it has eight wins, it is telling the truth while omitting the fact that sizes that truth: how many of those wins belonged to athletes who were racing in another brand's shoe last season.
Two companies, two non-comparable numbers
Here I repeat the complaint I make about football data. Adidas publishes a rate: nineteen per cent. Nike publishes a streak: six consecutive quarters of double-digit growth. Nike also says its max-cushion share nearly tripled — without saying on what base, in which market, over which period. Neither company discloses absolute running-segment revenue.
When neither side prints a denominator, comparison stops being accounting and becomes advertising.
The direct consequence is that this year's most repeated comparison — who overtook whom — is not provable from this material. A nineteen per cent increase does not say what share of group revenue running represents. It may be the group's big engine; it may be a small, bright, highly visible pocket. Without the denominator the two cannot be told apart, and what cannot be told apart should not be written as certainty.
Cost, restructuring and the bidding at the top
One more line belongs in its own column: the cost of competing here keeps rising. When costs rise and a rival is restructuring under a steep group revenue forecast, inflation in that market tends to be selective rather than broad. The bidding war will concentrate on the top eight or ten names, where one win carries a brand's entire story. This is an inference, not an established fact, and the next two windows will test it.
Whose initiative the 2026 change was
A date that appears in no press note. Adidas reshaped its development process in 2026, in the same period as a change at the top of the company and a turnaround programme. The timing coincides. That suggests the nine-month cycle is not a bottom-up engineering initiative but a management-driven transformation imposed from above. The distinction matters: change imposed from above moves fast and can retreat just as fast if the next leadership's priorities shift.
How durable the demand is
Here the account is cleanest. London splitting across two days, two hundred and fifty thousand applicants for New York, expected record turnout — together these say demand is coming from participation, not promotion. That is the more durable composition, because promotion ends and participation runs on. One condition attaches to it and cannot be ignored: the shoe sells in the hundreds of dollars. Participation-driven demand also contracts when discretionary spending contracts. The structure is strong and its doorway rests on one spending line.
The contrarian read: a file that reconciles and proves nothing
The easiest conclusion is that Adidas has overtaken Nike. I have no hard evidence to reject it, and that is the most important thing here. The file in front of me reconciles as follows: the nine-month cycle is real, the hundred-plus team is real, the eight wins are real, the Kipruto purchase is real. And then it fails to prove the one thing everyone wants proved — that the gap in wins is caused by the shoe. How many of those eight came from the shoe and how many from the recruitment network that catches athletes before the peak is not split in any document.
There is a second, less comfortable fact. Nike has said publicly it will innovate at a pace nobody has seen. Which means Adidas's biggest advantage — process — is the very thing its rival has already announced it is coming for. Process is expensive to copy, not impossible. And at the very top sits key-person dependency: a purchase as clever as Kipruto's is also fragile, because one injury can rewrite a season.
Writing an inversion is easy and it sells. I am equally willing to publish the null result, where the file reconciles and nothing is proven wrong. That is what happened here: both companies' accounts are correct, and the two are not comparable. Anyone writing this year that one overtook the other must first state which denominator he used.
The next domino
Sydney is the next stone. When it completes its second year in 2026, the first full fourteen-title season arrives and the comparison base finally becomes one. The question then is whether Nike's cuts convert into wins on the road or merely into a tidier ledger, and whether any company finds the nerve to publish absolute running revenue first. The day that number is printed, this argument ends — and it may turn out that the eight, on which so many stories were built, was always the arithmetic of something else.
